ANGO vs XOM · rev $292.5M vs P/E 24, rev $332.24B
AngioDynamics Inc (ANGO) versus Exxon Mobil Corp (XOM) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Exxon Mobil Corp (XOM) is a oil & gas integrated company listed on NYSE. It is led by Darren Woods.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported XOM revenue for 2025-12-31 was $332.24B. Net income was $28.84B. Revenue was down 5.0% from 2024-12-31 to 2025-12-31. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
ANGO currently screens at market cap $378.5M. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
Not investment advice. Open the ANGO and XOM stock pages for the full models.
Not investment advice.